Biochemical characterization of a GH53 endo-β-1,4-galactanase and a GH35 exo-β-1,4-galactanase from Penicillium chrysogenum

Applied Microbiology and Biotechnology
Tatsuji SakamotoNaoki Harada

Abstract

An endo-β-1,4-galactanase (PcGAL1) and an exo-β-1,4-galactanase (PcGALX35C) were purified from the culture filtrate of Penicillium chrysogenum 31B. Pcgal1 and Pcgalx35C cDNAs encoding PcGAL1 and PcGALX35C were isolated by in vitro cloning. The deduced amino acid sequences of PcGAL1 and PcGALX35C are highly similar to a putative endo-β-1,4-galactanase of Aspergillus terreus (70% amino acid identity) and a putative β-galactosidase of Neosartorya fischeri (72%), respectively. Pfam analysis revealed a "Glyco_hydro_53" domain in PcGAL1. PcGALX35C is composed of five distinct domains including "Glyco_hydro_35," "BetaGal_dom2," "BetaGal_dom3," and two "BetaGal_dom4_5" domains. Recombinant enzymes (rPcGAL1 and rPcGALX35C) expressed in Escherichia coli and Pichia pastoris, respectively, were active against lupin galactan. The reaction products of lupin galactan revealed that rPcGAL1 cleaved the substrate in an endo manner. The enzyme accumulated galactose and galactobiose as the main products. The smallest substrate for rPcGAL1 was β-1,4-galactotriose. On the other hand, rPcGALX35C released only galactose from lupin galactan throughout the reaction, indicating that it is an exo-β-1,4-galactanase. rPcGALX35C was active on both β-1,4-gala...Continue Reading

References

Aug 1, 1973·Analytical Biochemistry·N Blumenkrantz, G Asboe-Hansen
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A J BrakeP J Barr
Aug 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J P Knox
Sep 1, 1995·Bioscience, Biotechnology, and Biochemistry·F YamaguchiC Hatanaka
Dec 1, 1995·International Journal of Biological Macromolecules·E BonninJ F Thibault
Jun 20, 2001·Journal of Experimental Botany·A T CareyG A Tucker
Jun 27, 2001·Applied and Environmental Microbiology·T Sakamoto, J F Thibault
Jan 25, 2003·Carbohydrate Research·Kazuo OkemotoTakeshi Kasama
Dec 4, 2003·Biochimica Et Biophysica Acta·T SakamotoH Kawasaki
Oct 20, 2004·Journal of Molecular Biology·A L RojasI Polikarpov
May 4, 2005·The Journal of Biological Chemistry·Hitomi IchinoseSatoshi Kaneko
Feb 24, 2006·Bioscience, Biotechnology, and Biochemistry·Hong YangSatoshi Kaneko
Jul 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefan BauerChris R Somerville
Apr 12, 2008·PLoS Genetics·Natalie D FedorovaWilliam C Nierman
Sep 30, 2008·Nature Biotechnology·Marco A van den BergRoel A L Bovenberg
Feb 11, 2010·Critical Reviews in Biotechnology·Qayyum Husain
Sep 10, 2010·The Journal of Biological Chemistry·Melissa CidAlisdair B Boraston
Dec 7, 2010·Journal of Structural Biology·Mirko MaksimainenJuha Rouvinen
Dec 25, 2010·Applied Microbiology and Biotechnology·Tatsuji SakamotoNaoya Kasai
Jun 10, 2011·The Journal of Biological Chemistry·Toshihisa KotakeYoichi Tsumuraya
Jul 13, 2011·Applied Microbiology and Biotechnology·Tatsuji SakamotoToshiji Tada

❮ Previous
Next ❯

Citations

Nov 26, 2013·Applied Microbiology and Biotechnology·Estelle BonninMarie-Christine Ralet
May 15, 2013·Applied Microbiology and Biotechnology·Tatsuji Sakamoto, Megumi Ishimaru
Dec 2, 2014·Applied Microbiology and Biotechnology·Dorte M LarsenJørn D Mikkelsen
Jun 25, 2016·Applied Biochemistry and Biotechnology·Vasni Zavaleta, Jaime Eyzaguirre

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.